Global LVAD Market Report: 2013 Edition

Date: October 1, 2013
Pages: 47
US$ 800.00
Publisher: Koncept Analytics
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Global LVAD Market Report: 2013 Edition
LVADs are the mechanical devices which are implanted into the abdomen or chest and attached to a weakened heart to help it pump. LVADs are now sometimes used as an alternative to transplantation. LVAD is suitable for bridge-to-transplant market, which extends the patient’s life until a suitable donor is found, and for destination market, where patients suffer from heart failure but are not eligible for heart transplants, may be due to their age or some other illness that might get aggravated by heart transplantation. Due to increasing demand for both BTT and DT, LVAD market is increasing tremendously. Also, with the rapid technological advancements in this segment, LVADs are expected to become a viable treatment option for heart failure patients in the future.

The report examines the LVAD market on a global scale and its various segments. The use of bridge-to-transplant has been more than destination therapy and is expected to rise in coming years. On the regional basis, the US accounts for the major share of the patients using LVAD due to improved outcomes and lower complication rates of the newer devices in comparison with international patients.

The major factors driving the LVAD market includes growing ageing population, increasing diabetic population, reimbursement trends, expansion in the number of LVAD centers, rising healthcare expenditure and under-penetrated market. Also, growing bridge-to-transplant, which help patients to survive until a donor heart becomes available for transplant, is a major driver for LVAD market. But there are certain challenges which the industry is facing as of now which include barrier for DT adoption and safety issues.

The competition in the global LVAD market is intense with few large players viz. Thoratec Corporation, Heartware International Inc. and Abiomed Inc.. The global competitive landscape along with the company profiles of the leading players in the market is discussed in detail.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

1.1 Introduction
1.2 Various Stages of Heart Failure
1.3 Available Treatment Options for HF


2.1 Global LVAD Market
  Market Value & Volume
  Breakdown by Region
  Market Segments
2.2 The US LVAD Market
  Market Volume
  Market Segments


3.1 Growth Drivers
  3.1.1 Growing Bridge-to-transplant Market
  3.1.2 Ageing Population Worldwide
  3.1.3 Reimbursement Trends
  3.1.4 Expansion in the Number of LVAD Centers
  3.1.5 Under-Penetrated Market
  3.1.6 Increasing Diabetic Population
  3.1.7 Rising Healthcare Expenditure
3.2 Challenges
  3.2.1 Barriers for DT Adoption
  3.2.2 Safety Issues


Competitive Overview
Market Share
Product Comparison
4.1 United States
  Market Share
  Segment Share by Companies
4.2 International
  Market Share


5.1 Thoratec Corporation
  5.1.1 Business Description
  5.1.2 Financial Highlights
  5.1.3 Business Strategies
    Growth through Product Development
    Strategic Acquisitions
5.2 Heartware International Inc.
  5.2.1 Business Description
  5.2.2 Financial Highlights
  5.2.3 Business Strategies
    Growth through Acquisitions
5.3 Abiomed, Inc.
  5.3.1 Business Description
  5.3.2 Financial Highlights
  5.3.3 Business Strategies
    Research & Product Development
    Clinical Expertise in Cath Lab


6.1 Market Forecast
6.2 Forecast Methodology
  6.2.1 Dependent and Independent Variables
  6.2.2 Correlation Analysis
  6.2.3 Regression Analysis


Types of Heart Failure
Global LVAD Market (2008-2013E)
LVAD Pumps Sold Worldwide (2008-2013E)
Global LVAD Market – Value Share by Region (2013E)
The US Heart Transplant Donor Shortage (2006-2012)
Ageing Population Worldwide (2005-2013F)
LVAD Reimbursement Trend in the US (2006-2012)
Global Diabetic Population (2004-2012)
Healthcare Expenditure Worldwide (2005-2012E)
Global LVAD Market – Share by Leading Companies (2012)
United States LVAD Market – Share by Leading Companies (2012)
United States LVAD Bridge-to-Transplant Market – Share by Leading Companies (2012)
United States LVAD Destination Therapy Market – Share by Leading Companies (2012)
International LVAD Market – Share by Leading Companies (2012)
Thoratec Corporation Revenue-Share Breakdown by Product Line (2012)
Thoratec Corporation Revenue-Share Breakdown by Category (2012)
Thoratec Corporation Revenue-Share Breakdown by Region (2012)
Thoratec Corporation Revenue (2008-2012)
Heartware International Revenue – Share Breakdown by Region (2011)
Heartware International Revenue (2009-2012)
Abiomed’s Revenue: Share by Products (2013)
Revenue of Abiomed, Inc. (2009-2013)
Global LVAD Market (2011-2016F)


Stages of Heart Failure by AHA and ACC
NYHA Classification of Heart Failure
Global LVAD Market Statistics – by Application Area & Company (2009-2013E)
US LVAD Market - by Volume (2010-2014E)
CPT Codes for VAD Implantation
Product Comparison in LVAD Market
Dependent & Independent Variables (2008–2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Skip to top

Ask Your Question

Global LVAD Market Report: 2013 Edition
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: